Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer
Abstract Cardiotoxic manifestation associated with breast cancer treatment by anthracycline regimen increases patients’ susceptibility to myocardial injury, reduction in left ventricular ejection fraction and complications associated with heart failure. There is currently no standardized, minimally...
Guardado en:
Autores principales: | Hari Vishal Lakhani, Sneha S. Pillai, Mishghan Zehra, Benjamin Dao, Maria Tria Tirona, Ellen Thompson, Komal Sodhi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43f4b838effc46a2b3b54fd017e269af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetic basis of anthracyclines cardiotoxicity: Literature review
por: M. Yu. Sinitsky, et al.
Publicado: (2021) -
Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity
por: Caterina Beatrice Monti, et al.
Publicado: (2021) -
Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
por: Komal Sodhi, et al.
Publicado: (2021) -
Evaluation of the efficacy of global longitudinal strain in detection of anthracycline chemotherapy related cardiotoxicity
por: Rajesh Natuva, et al.
Publicado: (2021) -
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
por: Erika N. Scott, et al.
Publicado: (2021)